市場調査レポート - 208082

フランスの輸血検査市場

French Transfusion Testing Market

発行 Venture Planning Group
出版日 ページ情報 英文
価格
こちらの商品の販売は終了いたしました。
フランスの輸血検査市場 French Transfusion Testing Market
出版日: 2011年08月01日 ページ情報: 英文

当商品の販売は、2012年07月23日を持ちまして終了しました。

アップデート版(商品コード:238336)が出版されております、詳細はお問い合わせください。

概要

当レポートは、フランスの輸血検査市場について、経済情勢、規制、人口動態、社会および技術動向とともに、病院などで行われている血液型分類、感染症スクリーニングテストなどの販売量および売上予測、自動分析器の導入予測などを分析しまとめており、概略下記の内容でお届けいたします。

世界市場と技術概要

  • 主要な血液型、分類、および感染症スクリーニング検査
    • 主要な血液型およびグルーピング検査
    • 感染症スクリーニング検査
      • AIDS
      • 肝炎
      • サイトメガロウイルス
      • 梅毒
      • ウェストナイルウィルス
      • パルボウィルス B19
      • クロイツフェルト・ヤコブ病
      • マラリア
      • シャガス病
      • バベシア症
    • 病原体低減化
    • 白血球減少
  • 装置レビュー
  • 主な体外診断技術およびその潜在的なアプリケーション
    • 分子診断
    • モノクローナル抗体およびポリクローナル抗体
    • イムノアッセイ
    • マイクロ滴定プレート
    • 情報技術
    • 自動化
    • レーザー
    • ロボティクス
    • 人工知能
    • 人工赤血球
    • 遺伝工学的な血液成分
    • 血液保存
    • 自己輸血/冷凍
  • 世界の市場概要
    • ビジネス環境
    • 市場構造
    • 市場規模・成長

フランス

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模・成長・主要サプライヤーの消費者販売、装置の設置、インストールベースおよび市場シェア

主な製品開発の機会

  • 血液型、分類
  • 感染症スクリーニング
  • 補助製品

代替的市場浸透戦略

  • 社内開発
  • 提携契約
  • 大学との提携

市場参入障壁とリスク

  • 市場の成熟
  • 費用抑制
  • 競合
  • 技術力と限界
  • 特許の保護

競合評価

図表

目次

Abstract

Highlights

  • Comprehensive 430-page market segmentation analysis of the transfusion testing market.
  • Major issues pertaining to the French transfusion testing practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in French transfusion testing hospitals, and commercial laboratories.
  • Annual placements and installed base estimates for major automated and semi-automated analyzers.
  • Review of current instrumentation technologies, and a feature comparison of over 20 analyzers.
  • Ten-year reagent and instrument sales forecasts.
  • Sales and market shares of leading reagent and instrument suppliers.
  • Review of current and emerging technologies, and their potential market applications.
  • Product development opportunities for instruments, consumables, and auxiliary products.
  • Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
  • Business opportunities and strategic recommendations for suppliers.

Contains: 430 pages and 43 tables.

Table of Contents

Worldwide Technology and Market Overview

  • A. Major Blood Typing, Grouping and Infectious Disease Screening Tests
    • 1. Blood Typing and Grouping Tests
      • a. ABO
      • b. Antibody Panels
      • c. Antibody Screening
      • d. Antigen Typing
      • e. Antiglobulin Test
      • f. Crossmatch
      • g. HLA Typing
      • h. Rh
      • i. Other Blood Groups
    • 2. Infectious Disease Screening Tests
      • a. AIDS
        • Structure and Composition
        • Classification
        • Origin of AIDS
        • Animal Lentivirus Systems
        • Virus Receptors
        • HIV Infections in Humans
          • Pathogenesis & Pathology
          • Overview of Course of HIV Infection
        • CD4T Lymphocytes and Memory Cells
        • Monocytes and Macrophages
        • Lymphoid Organs
        • Neural Cells
        • Viral Coinfections
          • Clinical Findings
        • Plasma Viral Load
        • Pediactric AIDS
          • Neurologic Disease
          • Opportunistic Infections
          • Protozoa
          • Fungi
          • Bacteria
          • Viruses
          • Cancer
        • Immunity
        • Laboratory Diagnosis
          • Virus Isolation
          • Serology
          • Detection of Viral Nucleic Acid or Antigens
        • Epidemiology
          • Worldwide Spread of AIDS
          • United States
          • Routes of Transmission
        • Prevention, Treatment, And Control
          • Antiviral Drugs
          • Vaccines Against HIV
        • Transmission of HIV in Blood Products
        • HIV Transmission in Transplant and Artificial Insemination Recipients
        • Diagnostic Tests
          • Enzyme Immunoassay Interpretation
          • Specificity, Sensitivity, and Predictive Value of Enzyme Immunoassay
        • Competition Assays
        • Western Blot Technique
        • Immuno-Fluorescence Assay (IFA)
        • Radioimmunoprecipitation
        • HIV-1/HIV-2 Combination Testing
        • Methods of HIV-Antigen Detection
        • Antigen Assays and Blood Screening
        • Urine Tests
        • DNA Probes
        • Overview
        • Quantitative Polymerase Chain Reaction
        • In Situ PCR
        • Needed Improvements
        • Viral Load/Drug Resistance Testing
        • Genotype and Phenotype Testing
        • Blood Banking Considerations
      • b. Hepatitis
        • Hepatitis A
        • Hepatitis B
          • Structure and Composition
          • Replication of Hepatitis B Virus
        • Hepatitis C
        • Hepatitis D (Delta Hepatitis)
        • Hepatitis E
        • Hepatitis G
        • Hepatitis Virus Infections In Humans
          • Pathology
        • Clinical Findings
        • Laboratory Features
          • Hepatitis A
          • Hepatitis B
          • Hepatitis C
          • Hepatitis D
          • Hepatitis E
        • Virus-Host Immune Reactions
        • Epidemiology
          • Hepatitis A
          • Hepatitis B
          • Hepatitis C
          • Hepatitis D (Delta Agent)
        • Vaccines and Drugs
      • c. Cytomegalovirus
        • Background
        • Chorioretinitis
        • Gastrointestinal
        • Central Nervous System Disease
        • Diagnostic Tests
        • Vaccines and Drugs
      • d. Syphilis
        • Background
        • Diagnostic Tests
        • Vaccines and Drugs
      • e. West Nile Virus
        • Background
        • Clinical Syndromes
        • Diagnostic Tests
        • Vaccines and Drugs
      • f. Parvovirus B19
        • Microbiology
        • Epidemiology
        • Clinical Syndromes
          • Erythema Infectiosum Slapped (cheek)
          • Adult Polyarthropathy
          • Transient Aplastic Crisis
          • Transient Pancytopenia
          • Red Cell Aplasia in the Immunocompromised
          • Perinatal Infections
        • Diagnosis
        • Treatment
      • g. Creutzfeldt-Jakob' s Disease
        • Background
        • Transmission
        • Diagnostic Tests
        • Major Commercial and Academic Players
          • Bayer
          • Disease Sciences/BioTec Global
          • Imperial College School of Medicine
          • Ortho-Clinical Diagnostics
          • Pall
          • ProMetic Life Sciences
          • Proteome Sciences/Idexx
          • Q-One Biotech
          • Serono
          • U.S. Agricultural Research Service
        • Drugs
        • Vaccines
      • h. Malaria
      • i. Chagas Disease
      • j. Babesiosis
    • 3. Pathogen Reduction
    • 4. Leukocyte Reduction
      • Background
      • Methods
  • B. Instrumentation Review
    • Introduction
      • 1. Abbott Architect i2000 Series
      • 2. Abbott AxSYM
      • 3. Abbott LCx
      • 4. Abbott Prism
      • 5. Abbott Quantum II
      • 6. Beckman Coulter/Biomek FX
      • 7. Beckman Coulter BloodTrack Courier
      • 8. Beckman Coulter OLA2500
      • 9. Beckman Coulter PK7100
      • 10. Beckman Coulter PK7200
      • 11. Beckman Coulter PK80
      • 12. Beckman Coulter Tango
      • 13. Bio-Rad Elite
      • 14. Bio-Rad GeneScope
      • 15. BioMerieux Bac/Alert
      • 16. Gen-Probe Tigris
      • 17. Grifols Diana
      • 18. Immucor ABS2000
      • 19. Immucor Galileo
      • 20. Immucor Rosys Plato System
      • 21. Nanosphere Verigen Series
      • 22. Ortho AutoVue/ProVue
      • 23. Ortho StarFame Combo
      • 24. Ortho Summit Processor
      • 25. Roche Cobas Amplicor
      • 26. Roches Cobas s 201
      • 27. Sarstedt PVS
      • 28. Siemens BEP 2000
      • 29. Siemens Quadriga
      • 30. Siemens SDA
      • 31. Tecan ELPHAtyper
      • 32. Tecan Genesis FE500
      • 33. Tecan Hemotyper
      • 34. Tecan LS Series
      • 35. Tecan MegaFlex
      • 36. Tecan MiniSwift
  • C. Major in Vitro Diagnostic Technologies And Their Potential Applications
    • 1. Molecular Diagnostics
      • a. Overview
      • b. NAT
    • 2. Monoclonal and Polyclonal Antibodies
    • 3. Immunoassays
      • a. Technological Principle
      • b. Enzyme Immunoassays (EIA)
        • Overview
        • ELISA
        • Enzyme Amplification
      • c. Fluorescent Immunoassays
        • Fluorescence Polarization
      • d. Luminescence
        • Chemiluminescence
        • Bioluminescence
      • e. Latex Agglutination
      • f. Immunoprecipitation
    • 4. Microtitration Plates
    • 5. Information Technology
    • 6. Automation
    • 7. Lasers
    • 8. Robotics
    • 9. Artificial Intelligence
    • 10. Synthetic Red Cell Substitutes
    • 11. Genetically Engineered Blood Components
      • a. Albumin
      • b. Factor VIII
      • c. Alpha-2 Antiplasmin
      • d. Antithrombin III
      • e. Factor IX
      • f. Von Willebrand' s Factor
      • g. Fibrinogen
      • h. t-PA
    • 12. Blood Preservation
    • 13. Autologous Blood Transfusion/Freezing
  • D. Worldwide Market Overview
    • 1. Business Environment
    • 2. Market Structure
    • 3. Market Size and Growth

France

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers' Consumable Sales, Instrument Placements, Installed Base and Market Shares

Major Product Development Opportunities

  • A. Blood Typing and Grouping
  • B. Infectious Disease Screening
  • C. Auxiliary

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection

Competitive Assessments

  • Abbott
  • Beckman Coulter
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Diagast
  • DiaSorin
  • Fujirebio
  • Gen-Probe
  • Grifols
  • Immucor
  • Innogenetics
  • Ortho-Clinical Diagnostics
  • Orchid CellMark
  • Novartis Diagnostics
  • Proteome Sciences
  • Roche
  • Siemens
  • Tecan

List of Tables

  • Major Companies Developing or Marketing Blood Typing and Grouping Tests
  • Major Companies Developing or Marketing HLA Typing Tests
  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Blood Bank Analyzers
  • Worldwide, All Market Segments, Facilities Performing Blood Bank Tests By Country
  • Worldwide, All Market Segments, Total Blood Typing and Grouping Test Volume Forecast By Country
  • Worldwide, All Market Segments, Total Infectious Disease Screening Test Volume Forecast
  • Worldwide, All Market Segments, Total Blood Typing and Grouping Reagent Market Forecast By Country
  • Worldwide, All Market Segments, Total Infectious Disease Reagent Market Forecast By Country
  • Executive Summary Table: France, Total Blood Bank Test Volume and Reagent Sales Forecast By Test Category
  • France, Facilities Performing Blood Bank Tests By Market Segment
  • France, Hospital Laboratories Performing Blood Bank Tests By Bed Size
  • France, Commercial/Private Laboratories Performing Blood Bank Tests By Annual Test Volume
  • France, All Market Segments Blood Typing and Grouping Test Volume Forecast By Market Segment
  • France, All Market Segments Blood Typing and Grouping Test Volume Forecast
  • France, Hospital Laboratories Blood Typing and Grouping Test Volume Forecast
  • France, Blood Banks Blood Typing and Grouping Test Volume Forecast
  • France, Commercial/Private Laboratories Blood Typing and Grouping Test Volume Forecast
  • France, All Market Segments Infectious Disease Screening Test Volume Forecast By Market Segment
  • France, All Market Segments Infectious Disease Screening Test Volume Forecast
  • France, Blood Banks Infectious Disease Screening Test Volume Forecast
  • France, Commercial/Private Laboratories Infectious Disease Screening Test Volume Forecast
  • France, Hospital Laboratories Infectious Disease Screening Test Volume Forecast
  • France, All Market Segments Blood Typing and Grouping Reagent Market Forecast By Market Segment
  • France, All Market Segments Blood Typing and Grouping Reagent Market Forecast By Major Test
  • France, Hospital Laboratories Blood Typing and Grouping Reagent Market Forecast By Major
  • France, Blood Banks Blood Typing and Grouping Reagent Market Forecast By Major Test
  • France, Commercial/Private Laboratories Blood Typing and Grouping Reagent Market Forecast By Major Test
  • France, All Market Segments Infectious Disease Screening Reagent Market Forecast By Market Segment
  • France, All Market Segments Infectious Disease Screening Reagent Market Forecast By Test
  • France, Blood Banks Infectious Disease Screening Reagent Market Forecast By Test
  • France, Commercial/Private Laboratories Infectious Disease Screening Reagent Market Forecast By Test
  • France, Hospital Laboratories Infectious Disease Screening Reagent Market Forecast By Test
  • France, Major Suppliers of Blood Typing and Grouping Reagents Estimated Sales and Market Shares
  • France, HIV/HTLV Screening Market, Reagent Sales By Major Supplier
  • France, Hepatitis Blood Screening Market, Reagent Sales By Major Supplier
  • France, HIV/Hepatitis NAT Screening Market Reagent Sales by Major Supplier
  • France, CMV Blood Screening Market, Reagent Sales By Major Supplier
  • France, Syphilis Blood Screening Market, Reagent Sales By Major Supplier
  • France, Major Suppliers of Blood Bank Automated Analyzers, Estimated Placements and Installed Base By Supplier and Model
Back to Top